Tempest Therapeutics, Inc. (TPST): Gross Profit

Revenue minus cost of revenue for the same annual period and currency, computed by TickerFacts from the filed figures. The issuer may report gross profit or margin on a different basis.

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Older than the company's other figures. The latest Gross Profit is for the year ended 2017-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

-$495.0K
Year ended 2017-12-31
2015-12-31: -$1.97M2016-12-31: -$4.75M2017-12-31: -$495.0K-$495.0K
2015-12-31 Gross Profit (USD) 2017-12-31
Period endedGross ProfitChange YoYSource filing
2017-12-31-$495.0Kn/m2018-03-15, From 2017-01-01
2016-12-31-$4.75Mn/m2018-03-15, From 2016-01-01
2015-12-31-$1.97Mn/a2018-03-15, From 2015-01-01